Trial Profile
High Dose Candesartan Versus Quinapril for Restenosis Prophylaxis After Stent Angioplasty
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Sep 2013
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil (Primary) ; Quinapril
- Indications Coronary artery restenosis; Restenosis
- Focus Therapeutic Use
- 02 Oct 2006 Status change
- 31 Dec 2005 New trial record.